Ozempic® (semaglutide) carries a **boxed warning** about the potential risk of thyroid C-cell tumors. This warning is based on findings from laboratory animals. It is **not known whether Ozempic causes thyroid C-cell tumors in humans**. Ozempic should **not be used by people with a personal or family history of medullary thyroid carcinoma (MTC)** or by people with **Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)**. If you experience symptoms such as a **lump or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath**, discuss them with a healthcare professional. The prescribing information for Ozempic also includes other serious or potentially serious risks, including: • Pancreatitis • Diabetic retinopathy complications • Hypoglycemia when used with certain diabetes medications • Acute kidney injury • Gallbladder problems • Serious allergic reactions • Severe gastrointestinal adverse reactions One important point: **More potential side effects do not necessarily mean a medication is bad or inappropriate.** Every prescription medication has potential benefits and risks. The important question is whether the medication is appropriate for a particular person and their medical situation. If you have been prescribed Ozempic, talk with your healthcare professional or pharmacist about why you are taking it, your prescribed dose, potential side effects, and what to do if you have concerns. **Educational Disclaimer:** This video is for educational and informational purposes only and is not medical advice, diagnosis, or treatment. Always consult your healthcare professional or pharmacist for advice about your individual health and medications. Do not stop, start, or change a prescribed medication without speaking with a qualified healthcare professional. **Source:** Ozempic® (semaglutide) Prescribing Information, Novo Nordisk. #ozempic #semaglutide #type2diabetes #diabetes #diabetesmedication #ozempicsideeffects #semaglutidefacts #diabetescare #diabeteseducation #rehealthify